All companies
Visit website
Ionica Sciences, Inc.
OperatingIonica Sciences
Founded 2013
A better way to test for Lyme disease
Valuation cap ⓘ
$5.5M
As of Nov 2020 · from Ionica Sciences, Inc. Convertible Note 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$83,400
Across 1 round since 2020
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its source$0
−$41K
2018
$0
−$325K
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$40,643
-$325,300
Taxes paid
$0
$0
Balance sheet
Cash
$300,890
$139,160
Accounts receivable
$0
$0
Total assets
$375,663
$232,502
Short-term debt
$43,544
$293,928
Long-term debt
$225,000
$0
Total liabilities
$268,544
$293,928
Other
Headcount
—
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$5.5M
Valuation cap
Ionica Sciences, Inc. Convertible Note 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $83.4K / $750KValuation cap $5.5M
Reg CF annual-report compliance
Delinquent
Filed 0 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2021, 2022, 2023, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form CAug 21, 20200001817637-20-000002EDGAR
Source: ManualCIK 0001817637
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.